US Patent Issued to Regeneron Pharmaceuticals on Sept. 29 for "Methods of identifying and evaluating cat allergy gene signatures in a subject by determining a stratified score based on gene expression" (New York Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,287, issued on Sept. 29, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Methods of identifying and evaluating cat allergy gene signatures in a subject by determining a stratified score based on gene expression" was invented by Matthew F. Wipperman (Tarrytown, N.Y.), Kaitlyn Gayvert (Tarrytown, N.Y.), Wei Keat Lim (Tarrytown, N.Y.), Jennifer D. Hamilton (Tarrytown, N.Y.), Sara C. Hamon (Tarrytown, N.Y.) and Meagan O'Brien (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of identifying a subject as suitable for the treatment or prevention of asthma exacerbation induced by a ca...